Table 2. Proportions and timing of... | American Society of Hematology

Table 2.

Proportions and timing of CAR-T–associated neurotoxicity

Neurotoxicity, CTCAE version 5.0	Patients who were evaluable (n = 20)
Rating by CAR-T day 30
Any grade, n (%)	10 (50)∗
Grade ≥3, n (%)	5 (25)
Median event duration, d (range)
Any grade	24 (8-39)†
Grade ≥3	7 (2-28)

Neurotoxicity, CTCAE version 5.0	Patients who were evaluable (n = 20)
Rating by CAR-T day 30
Any grade, n (%)	10 (50)∗
Grade ≥3, n (%)	5 (25)
Median event duration, d (range)
Any grade	24 (8-39)†
Grade ≥3	7 (2-28)

CTCAE, Common Terminology Criteria for Adverse Events.

Value is unadjusted for stage 1 analysis.

Event duration was calculated from the onset of the first CAR-T neurotoxicity event to the end date of the last CAR-T neurotoxicity event.